Ginkgo Bioworks Holdings, Inc.DNANYSE
LOADING
|||
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-26.96%
↓ 127% below average
Average (5y)
100.87%
Historical baseline
Range
High:619.59%
Low:-44.84%
Volatility
658.7%
High variability
| Period | Value |
|---|---|
| 2024 | -26.96% |
| 2023 | -44.84% |
| 2022 | -8.44% |
| 2021 | 619.59% |
| 2020 | 65.91% |
| 2019 | 0.00% |